Magnetic nanoparticles have attracted attention because of their current and potential usefulness as contrast agents for magnetic resonance imaging (MRI) or colloidal mediators for cancer magnetic hyperthermia. This review examines these in vivo applications through an understanding of the involved problems and the current and future possibilities for resolving them. A special emphasis is made on magnetic nanoparticle requirements from a physical viewpoint (e.g. relaxivity for MRI and specific absorption rate for hyperthermia), the factors affecting their biodistribution (e.g. size, surface hydrophobic/hydrophilic balance, etc.) and the solutions envisaged for enhancing their half-life in the blood compartment and targeting tumour cells.

Because the Roman god Janus was usually represented with two heads placed back to back, the term Janus is used for the description of particles whose surfaces of both hemispheres are different from a chemical point of view. So, they could be used as building blocks for supraparticular assemblies, as dual-functionalized devices, as particular surfactants if one hemisphere is hydrophilic and the other hydrophobic, etc. If they could allow the segregation of negative charges on one hemisphere and positive charges on the other one, they would display a giant dipole moment allowing their remote positioning by rotation in an electric field as a function of field polarity. This review deals with the great and imaginative efforts which were devoted to the synthesis of Janus particles in the last fifteen years. A special emphasis is made on scalable techniques and on those which apply to the preparation of Janus particles in the nanometer range. Specific properties and applications of Janus particles are discussed.

Magnetic nanoparticles have attracted attention in modern medicine and pharmacology owing to their potential usefulness as contrast agents for MRI, as colloidal mediators for cancer magnetic hyperthermia or as active constituents of drug-delivery platforms. This review examines these in vivo applications through an understanding of the involved problems and the current and future possibilities for resolving them. A special emphasis is placed upon magnetic nanoparticle requirements from a physical viewpoint (e.g., relaxivity for MRI, specific absorption rate for hyperthermia and magnetic guidance), the factors affecting their biodistribution after intravenous injection (e.g., size and surface hydrophobic/hydrophilic balance) and the solutions envisaged for enhancing their half-life in the blood compartment and in targeting tumor cells.